Former Insys Therapeutics CEO Michael Babich has agreed to pay $30 million to settle claims brought by the Insys Liquidation Trust, which has been seeking to recover tens of millions of dollars from former company executives over their roles in the aggressive marketing of the opioid painkiller Subsys, according to a settlement filed Friday in